Critical skin cancer in organ transplant recipients - A dermatopathological view

Current Problems in Dermatology

Volumn 43, Issue , 2012, Pages 18-35

  Kempf, Werner ^a,b   Mertz, Kirsten D ^a,c   Kanitakis, Jean ^d   Hofbauer, Gnther F L ^b  

^a Kempf and Pfaltz   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Kantonsspital Liestal   (Switzerland)

^d EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTHRACYCLINE; BLEOMYCIN; CD56 ANTIGEN; CHROMOGRANIN; G PROTEIN COUPLED RECEPTOR; PROTEIN PATCHED; SYNAPTOPHYSIN;

ACTINIC KERATOSIS; ARTICLE; BASAL CELL; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER CELL; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RISK; CELL GROWTH; CELL INVASION; CLINICAL FEATURE; ENVIRONMENTAL EXPOSURE; EPITHELIUM CELL; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KERATINIZATION; MELANOMA; MERKEL CELL TUMOR; MULTIMODALITY CANCER THERAPY; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; PRECURSOR; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEBORRHEIC KERATOSIS; SEX DIFFERENCE; SKIN CARCINOGENESIS; SKIN LYMPHOMA; SKIN ULCER; SOFT TISSUE TUMOR; SQUAMOUS CELL CARCINOMA; SWEAT GLAND TUMOR; TUMOR DIFFERENTIATION; ULTRAVIOLET RADIATION;

CARCINOMA, BASAL CELL; CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOCOMPROMISED HOST; LYMPHOMA; MELANOMA; ORGAN TRANSPLANTATION; PROGNOSIS; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 84859187757     PISSN: 14215721     EISSN: 16622944     Source Type: Book Series    
DOI: 10.1159/000335144     Document Type: Article

References (79)

1. Euvrard S, Kanitakis J, Pouteil-Noble C, Dureau G, Touraine JL, Faure M, Claudy A, Thivolet J: Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995;33:222-229.
2. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, Fauchald P, Simonsen S: Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999;40:177-186.
3. Euvrard S, Kanitakis J, Claudy A: Skin cancers after organ transplantation. N Engl J Med 2003;348: 1681-1691.
4. Cooper SM, Wojnarowska F: The accuracy of clinical diagnosis of suspected premalignant and malignant skin lesions in renal transplant recipients. Clin Exp Dermatol 2002;27:436-438.
5. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS: Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000;143: 513-519.
6. Wisgerhof HC, van der Geest LG, de Fijter JW, Haasnoot GW, Claas FH, le Cessie S, Willemze R, Bouwes Bavinck JN: Incidence of cancer in kidneytransplant recipients: A long-term cohort study in a single center. Cancer Epidemiol 2011;35:105-111.
7. Harwood CA, McGregor JM, Swale VJ, Proby CM, Leigh IM, Newton R, Khorshid SM, Cerio R: High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients. J Am Acad Dermatol 2003;48:401-408.
8. Lally A, Casabonne D, Waterboer T, Imko-Walczuk B, Michael KM, Pawlita M, Newton R, Wojnarowska F: Association of seborrhoeic warts with skin cancer in renal transplant recipients. J Eur Acad Dermatol Venereol 2010;24:302-307.
9. Weedon D, Morgan MB, Gross C, Nagore E, Yu LL: Squamous cell carcinoma; in Weedon D, LeBoit P, Burg G, Sarasin A: Pathology and Genetics. Skin Tumours. Lyon, IARC, 2006, pp 20-25.
10. Smith KJ, Hamza S, Skelton H: Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004;30:634-641.
11. Hoyo E, Kanitakis J, Euvrard S, Thivolet J: Proliferation characteristics of cutaneous squamous cell carcinomas developing in organ graft recipients. Comparison with squamous cell carcinomas of nonimmunocompromised hosts by counting argyrophilic proteins associated with nucleolar organizer regions. Arch Dermatol 1993;129:324-327.
12. Farasat S, Yu SS, Neel VA, Nehal KS, Lardaro T, Mihm MC, Byrd DR, Balch CM, Califano JA, Chuang AY, Sharfman WH, Shah JP, Nghiem P, Otley CC, Tufaro AP, Johnson TM, Sober AJ, Liegeois NJ: A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011;64:1051-1059.
13. Breuninger H, Black B, Rassner G: Microstaging of squamous cell carcinomas. Am J Clin Pathol 1990; 94:624-627.
14. Petter G, Haustein UF: Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg 2000;26:521-530.
15. Harwood CA, Proby CM, McGregor JM, Sheaff MT, Leigh IM, Cerio R: Clinicopathologic features of skin cancer in organ transplant recipients: A retrospective case-control series. J Am Acad Dermatol 2006;54:290-300.
16. Gibson GE, O'Grady A, Kay EW, Leader M, Murphy GM: P53 tumor suppressor gene protein expression in premalignant and malignant skin lesions of kidney transplant recipients. J Am Acad Dermatol 1997;36:924-931.
17. Muhleisen B, Petrov I, Gachter T, Kurrer M, Schaerer L, Dummer R, French LE, Hofbauer GF: Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate. Histopathology 2009;55: 67-76.
18. Bouwes Bavinck JN, Neale RE, Abeni D, Euvrard S, Green AC, Harwood CA, de Koning MN, Naldi L, Nindl I, Pawlita M, Pfister H, Proby CM, Quint WG, ter Schegget J, Waterboer T, Weissenborn S, Feltkamp MC: Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res 2010;70: 9777-9786.
19. Ternesten-Bratel A, Kjellstrom C, Wennberg AM, Ricksten A: Cutaneous squamoproliferative lesions in kidney transplant recipients: An investigation of specific Epstein-Barr virus expression. Acta Derm Venereol 2003;83:14-17.
20. Ulrich C, Kanitakis J, Stockfleth E, Euvrard S: Skin cancer in organ transplant recipients-where do we stand today? Am J Transplant 2008;8:2192-2198.
21. Hofbauer GF, Anliker M, Arnold A, Binet I, Hunger R, Kempf W, Laffitte E, Lapointe AC, Pascual M, Pelloni F, Serra A: Swiss clinical practice guidelines for skin cancer in organ transplant recipients. Swiss Med Wkly 2009;139:407-415.
22. O'Reilly Zwald F, Brown M: Skin cancer in solid organ transplant recipients: Advances in therapy and management. II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011;65:263-279.
23. Rival-Tringali AL, Euvrard S, Decullier E, Claudy A, Faure M, Kanitakis J: Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas. Anticancer Res 2009;29:1927-1932.
24. Smit JV, de Sevaux RG, Blokx WA, van de Kerkhof PC, Hoitsma AJ, de Jong EM: Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: Histologic and immunohistochemical effects. J Am Acad Dermatol 2004;50:189-196.
25. Mertz KD, Proske D, Kettelhack N, Kegel C, Keusch G, Schwarz A, Ambuhl PM, Pfaltz M, Kempf W: Basal cell carcinoma in a series of renal transplant recipients: Epidemiology and clinicopathologic features. Int J Dermatol 2010;49:385-389.
26. Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM: A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006;154:498-504.
27. Kanitakis J, Alhaj-Ibrahim L, Euvrard S, Claudy A: Basal cell carcinomas developing in solid organ transplant recipients: Clinicopathologic study of 176 cases. Arch Dermatol 2003;139:1133-1137.
28. Saldanha G, Fletcher A, Slater DN: Basal cell carcinoma: A dermatopathological and molecular biological update. Br J Dermatol 2003;148:195-202.
29. Kossard S, Epstein Jr EH, Cerio R, Yu LL, Weedon D: Basal cell carcinoma; in Weedon D, LeBoit P, Burg G, Sarasin A: Skin Tumours. Pathology and Genetics. WHO Classification of Tumours. Lyon, IARC, 2006, pp 13-19.
30. Ulrich M, Roewert-Huber J, Gonzalez S, Rius-Diaz F, Stockfleth E, Kanitakis J: Peritumoral clefting in basal cell carcinoma: Correlation of in vivo reflectance confocal microscopy and routine histology. J Cutan Pathol 2011;38:190-195.
31. Mougel F, Kanitakis J, Faure M, Euvrard S: Basosquamous cell carcinoma in organ transplant patients: A clinicopathologic study. J Am Acad Dermatol, DOI: 10.1016/j.jaad.2010.1011.1045.
32. Buell JF, Trofe J, Hanaway MJ, Beebe TM, Gross TG, Alloway RR, First MR, Woodle ES: Immunosuppression and Merkel cell cancer. Transplant Proc 2002;34:1780-1781.
33. Koljonen V, Kukko H, Tukiainen E, Bohling T, Sankila R, Pukkala E, Sihto H, Joensuu H, Kyllonen L, Makisalo H: Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol Dial Transplant 2009;24:3231-3235.
34. Penn I, First MR: Merkel's cell carcinoma in organ recipients: Report of 41 cases. Transplantation 1999; 68:1717-1721.
35. Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Penas PF, Nghiem P: Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: The AEIOU features. J Am Acad Dermatol 2008;58: 375-381.
36. Kanitakis J, Euvrard S, Chouvet B, Butnaru AC, Claudy A: Merkel cell carcinoma in organ-transplant recipients: Report of two cases with unusual histological features and literature review. J Cutan Pathol 2006;33:686-694.
37. D'Agostino M, Cinelli C, Willard R, Hofmann J, Jellinek N, Robinson-Bostom L: Epidermotropic Merkel cell carcinoma: A case series with histopathologic examination. J Am Acad Dermatol 2010; 62:463-468.
38. Vazmitel M, Michal M, Kempf W, Mukensnabl P, Kazakov DV: Merkel cell carcinoma with a follicular lymphocytic infiltrate: Report of 2 cases. Am J Dermatopathol 2008;30:389-391.
39. Lemos BD, Storer BE, Iyer JG, Phillips JL, Bichakjian CK, Fang LC, Johnson TM, Liegeois-Kwon NJ, Otley CC, Paulson KG, Ross MI, Yu SS, Zeitouni NC, Byrd DR, Sondak VK, Gershenwald JE, Sober AJ, Nghiem P: Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010;63:751-761.
40. Feng H, Shuda M, Chang Y, Moore PS: Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-1100.
41. Duncavage EJ, Le BM, Wang D, Pfeifer JD: Merkel cell polyomavirus: A specific marker for Merkel cell carcinoma in histologically similar tumors. Am J Surg Pathol 2009;33:1771-1777.
42. Ridd K, Yu S, Bastian BC: The presence of polyomavirus in non-melanoma skin cancer in organ transplant recipients is rare. J Invest Dermatol 2009;129: 250-252.
43. Mertz KD, Pfaltz M, Junt T, Schmid M, Fernandez Figueras MT, Pfaltz K, Barghorn A, Kempf W: Merkel cell polyomavirus is present in common warts and carcinoma in situ of the skin. Hum Pathol 2010;41:1369-1379.
44. Mertz KD, Junt T, Schmid M, Pfaltz M, Kempf W: Inflammatory monocytes are a reservoir for Merkel cell polyomavirus. J Invest Dermatol 2010;130:1146-1151.
45. Rao P, Balzer BL, Lemos BD, Liegeois NJ, McNiff JM, Nghiem P, Prieto VG, Smith MT, Smoller BR, Wick MR, Frishberg DP: Protocol for the examination of specimens from patients with Merkel cell carcinoma of the skin. Arch Pathol Lab Med 2010; 134:341-344.
46. Harwood CA, Swale VJ, Bataille VA, Quinn AG, Ghali L, Patel SV, Dove-Edwin I, Cerio R, McGregor JM: An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol 2001; 116:246-253.
47. Kanitakis J, Euvrard S, Sebbag L, Claudy A: Trichilemmal carcinoma of the skin mimicking a keloid in a heart transplant recipient. J Heart Lung Transplant 2007;26:649-651.
48. Hollenbeak CS, Todd MM, Billingsley EM, Harper G, Dyer AM, Lengerich EJ: Increased incidence of melanoma in renal transplantation recipients. Cancer 2005;104:1962-1967.
49. Penn I: Malignant melanoma in organ allograft recipients. Transplantation 1996;61:274-278.
50. Brewer JD, Christenson LJ, Weaver AL, Dapprich DC, Weenig RH, Lim KK, Walsh JS, Otley CC, Cherikh W, Buell JF, Woodle ES, Arpey C, Patton PR: Malignant melanoma in solid transplant recipients: Collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. Arch Dermatol 2011;147: 790-796.
51. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C: Cancer after kidney transplantation in the United States. Am J Transplant 2004;4:905-913.
52. Le Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F: Melanomas in renal transplant recipients. Br J Dermatol 2006;154:472-477.
53. Matin RN, Mesher D, Proby CM, McGregor JM, Bouwes Bavinck JN, del Marmol V, Euvrard S, Ferrandiz C, Geusau A, Hackethal M, Ho WL, Hofbauer GF, Imko-Walczuk B, Kanitakis J, Lally A, Lear JT, Lebbe C, Murphy GM, Piaserico S, Seckin D, Stockfleth E, Ulrich C, Wojnarowska FT, Lin HY, Balch C, Harwood CA: Melanoma in organ transplant recipients: Clinicopathological features and outcome in 100 cases. Am J Transplant 2008;8: 1891-1900.
54. Kanitakis J, Baldassini S, Lora V, Euvrard S: BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipients. Eur J Dermatol 2010;20:167-171.
55. Pedagogos E, Nicholls K, Dowling J, Becker G: Kaposi's sarcoma post renal transplantation. Aust N Z J Med 1994;24:722-723.
56. Penn I: Cancers in renal transplant recipients. Adv Ren Replace Ther 2000;7:147-156.
57. Montagnino G, Bencini PL, Tarantino A, Caputo R, Ponticelli C: Clinical features and course of Kaposi's sarcoma in kidney transplant patients: Report of 13 cases. Am J Nephrol 1994;14:121-126.
58. Frances C: Kaposi's sarcoma after renal transplantation. Nephrol Dial Transplant 1998;13:2768-2773.
59. Dreno B: Skin cancers after transplantation. Nephrol Dial Transplant 2003;18:1052-1058.
60. Frances C, Marcelin AG, Legendre C, Chevret S, Dussaix E, Lejeune J, Euvrard S, Bigorie A, Schulz TF, Agbalika F, Lebbe C: The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survival. Am J Transplant 2009;9:2580-2586.
61. Kempf W, Cathomas G, Burg G, Trueb RM: Micronodular Kaposi's sarcoma-a new variant of classic-sporadic Kaposi's sarcoma. Dermatology 2004;208:255-258.
62. Grayson W, Pantanowitz L: Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol 2008;3:31.
63. Kazakov DV, Prinz BM, Michaelis S, Schmid M, Muller B, Adams V, Burg G, Kempf W: Study of HHV-8 DNA sequences in archival biopsies from lesional skin of Kaposi's sarcoma, various mesenchymal tumors and related reactive conditions. J Cutan Pathol 2002;29:279-281.
64. Robin YM, Guillou L, Michels JJ, Coindre JM: Human herpesvirus 8 immunostaining: A sensitive and specific method for diagnosing Kaposi sarcoma in paraffin-embedded sections. Am J Clin Pathol 2004;121:330-334.
65. Antman K, Chang Y: Kaposi's sarcoma. N Engl J Med 2000;342:1027-1038.
66. Woodle ES, Hanaway M, Buell J, Gross T, First MR, Trofe J, Beebe T: Kaposi sarcoma: An analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry. Transplant Proc 2001;33:3660-3661.
67. Euvrard S, Kanitakis J, Bosshard S, Lebbe C, Garnier JL, Touraine JL, Claudy A: No recurrence of posttransplantation Kaposi's sarcoma three years after renal retransplantation. Transplantation 2002;73: 297-299.
68. Brooks JJ: Kaposi's sarcoma: A reversible hyperplasia. Lancet 1986;2:1309-1311.
69. Hofbauer GF, Bouwes Bavinck JN, Euvrard S: Organ transplantation and skin cancer: Basic problems and new perspectives. Exp Dermatol 2010;19:473-482.
70. Mitsuyasu RT: Update on the pathogenesis and treatment of Kaposi sarcoma. Curr Opin Oncol 2000;12:174-180.
71. Prinz BM, Hofbauer GF, Dummer R, French LE, Kempf W: Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal transplant recipients-a clinico-pathological observation. Clin Exp Dermatol 2011, in press.
72. Penn I: Sarcomas in organ allograft recipients. Transplantation 1995;60:1485-1491.
73. Kanitakis J, Euvrard S, Montazeri A, Garnier JL, Faure M, Claudy A: Atypical fibroxanthoma in a renal graft recipient. J Am Acad Dermatol 1996;35: 262-264.
74. Hafner J, Kunzi W, Weinreich T: Malignant fibrous histiocytoma and atypical fibroxanthoma in renal transplant recipients. Dermatology 1999;198:29-32.
75. Kovach BT, Sams HH, Stasko T: Multiple atypical fibroxanthomas in a cardiac transplant recipient. Dermatol Surg 2005;31:467-470.
76. Swerdlow SH, Webber SA, Chadburn A, Ferry JA: Post-transplant lymphoproliferative disorders; in Swerdlow SH, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC, 2008, pp 343-349.
77. Beynet DP, Wee SA, Horwitz SS, Kohler S, Horning S, Hoppe R, Kim YH: Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients. Arch Dermatol 2004;140:1140-1146.
78. Yurtsever H, Kempf W, Laeng RH: Posttransplant CD30+ anaplastic large cell lymphoma with skin and lymph node involvement. Dermatology 2003; 207:107-110.
79. Kempf W, Sander CA: Classification of cutaneous lymphomas-an update. Histopathology 2010;56: 57-70.